These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15364321)

  • 1. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.
    Jeremias A; Baim DS; Ho KK; Chauhan M; Carrozza JP; Cohen DJ; Popma JJ; Kuntz RE; Cutlip DE
    J Am Coll Cardiol; 2004 Sep; 44(6):1210-4. PubMed ID: 15364321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.
    Ramsay J; Shernan S; Fitch J; Finnegan P; Todaro T; Filloon T; Nussmeier NA
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):300-6. PubMed ID: 15678039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.
    Pervaiz MH; Sood P; Sudhir K; Hermiller JB; Hou L; Hattori K; Su X; Cao S; Wang J; Applegate RJ; Kereiakes DJ; Yaqub M; Stone GW; Cutlip DE
    Circ Cardiovasc Interv; 2012 Apr; 5(2):150-6. PubMed ID: 22438430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality at 30 days in high-risk patients treated with direct or rescue stenting for acute myocardial infarction: a single center experience.
    La Vecchia L; Martini M; Sartori M; Vincenzi P; Cischele L; Righetti T; Ometto R; Fontanelli A
    J Invasive Cardiol; 2001 Oct; 13(10):689-93. PubMed ID: 11581511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of the elevation of the indices of myocardial damage after percutaneous coronary revascularization interventions].
    Cavallini C; Savonitto S
    Ital Heart J Suppl; 2002 Mar; 3(3):286-96. PubMed ID: 12040844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.
    Hassani SE; Chu WW; Wolfram RM; Kuchulakanti PK; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
    J Invasive Cardiol; 2006 Jun; 18(6):273-7. PubMed ID: 16751681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction.
    Choi JW; Gibson CM; Murphy SA; Davidson CJ; Kim RJ; Ricciardi MJ
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):472-6. PubMed ID: 15065140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry.
    Zahn R; Hamm CW; Schneider S; Zeymer U; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Sabin G; Nienaber CA; Senges J;
    Am Heart J; 2006 Dec; 152(6):1146-52. PubMed ID: 17161068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis.
    Ajani AE; Waksman R; Sharma AK; Lew R; Pinnow E; Canos DA; Cheneau E; Castagna M; Cha DH; Leborgne L; Satler LF; Pichard AD; Kent KM; Lindsay J
    Am J Cardiol; 2004 Feb; 93(3):313-7. PubMed ID: 14759380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial.
    Balducelli M; Varani E; Vecchi G; Paloscia L; Manari A; Santarelli A; Cappi B; Shoeib A; Valenti S; Maresta A;
    Minerva Cardioangiol; 2007 Jun; 55(3):281-9. PubMed ID: 17534246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker.
    Wang FW; Osman A; Otero J; Stouffer GA; Waxman S; Afzal A; Anzuini A; Uretsky BF
    Circulation; 2003 Jun; 107(23):2914-9. PubMed ID: 12771007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque.
    Fujii K; Carlier SG; Mintz GS; Kobayashi Y; Jacoboff D; Nierenberg H; Takebayashi H; Yasuda T; Moussa I; Dangas G; Mehran R; Lansky AJ; Kreps EM; Collins M; Stone GW; Leon MB; Moses JW
    Am J Cardiol; 2005 Feb; 95(3):355-9. PubMed ID: 15670544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.